About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Ptpn22
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
MGI:107170
62 phenotypes from 5 alleles in 4 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Gt(ROSA)26Sortm1(Ptpn22*)Draw/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
involves: 129P2/OlaHsd * C57BL/6
enlarged spleen J:201448
expanded mesangial matrix J:201448
glomerulonephritis J:201448
increased anti-double stranded DNA antibody level J:201448
increased autoantibody level J:201448
increased B cell number J:201448
increased germinal center B cell number J:201448
spleen hyperplasia J:201448
Ptpn22tm1.1Draw/Ptpn22+
involves: 129 * C57BL/6
abnormal B cell differentiation J:201448
abnormal B cell morphology J:201448
abnormal B cell number J:201448
abnormal B cell physiology J:201448
abnormal T cell morphology J:201448
abnormal T cell number J:201448
abnormal T cell physiology J:201448
abnormal thymus morphology J:201448
autoimmune response J:201448
decreased B cell apoptosis J:201448
decreased follicular B cell number J:201448
decreased mature B cell number J:201448
enlarged spleen J:201448
increased anti-double stranded DNA antibody level J:201448
increased B cell number J:201448
increased B cell proliferation J:201448
increased CD4-positive, alpha-beta memory T cell number J:201448
increased double-positive T cell number J:201448
increased germinal center B cell number J:201448
increased IgG1 level J:201448
increased interleukin-2 secretion J:201448
increased regulatory T cell number J:201448
increased spleen germinal center size J:201448
increased T cell proliferation J:201448
increased transitional stage T1 B cell number J:201448
spleen hyperplasia J:201448
thymus hyperplasia J:201448
Ptpn22tm1.1Draw/Ptpn22tm1.1Draw
involves: 129 * C57BL/6
abnormal B cell activation J:201448
abnormal B cell differentiation J:201448
abnormal B cell morphology J:201448
abnormal B cell physiology J:201448
abnormal lung morphology J:201448
abnormal salivary gland morphology J:201448
abnormal T cell differentiation J:201448
abnormal T cell morphology J:201448
abnormal T cell physiology J:201448
abnormal thymus morphology J:201448
autoimmune response J:201448
decreased B cell apoptosis J:201448
decreased follicular B cell number J:201448
decreased mature B cell number J:201448
enlarged spleen J:201448
glomerulonephritis J:201448
normal immune system phenotype J:201448
increased anti-double stranded DNA antibody level J:201448
increased anti-insulin autoantibody level J:201448
increased B cell number J:201448
increased B cell proliferation J:201448
increased double-positive T cell number J:201448
increased effector memory CD4-positive, alpha-beta T cell number J:201448
increased effector memory CD8-positive, alpha-beta T cell number J:201448
increased germinal center B cell number J:201448
increased IgE level J:201448
increased IgG1 level J:201448
increased IgG3 level J:201448
increased IgM level J:201448
increased inflammatory response J:201448
increased interleukin-2 secretion J:201448
increased physiological sensitivity to xenobiotic J:201448
increased regulatory T cell number J:201448
increased spleen germinal center size J:201448
increased T cell proliferation J:201448
increased transitional stage T1 B cell number J:201448
premature death J:201448
spleen hyperplasia J:201448
thymus hyperplasia J:201448
vascular inflammation J:201448
Ptpn22tm1.1Kas/Ptpn22tm1.1Kas
involves: C57BL/6
abnormal dendritic cell physiology J:176519
enlarged spleen J:176519
enlarged thymus J:176519
normal immune system phenotype J:176519
increased B cell proliferation J:176519
increased CD4-positive, alpha-beta T cell number J:176519
increased CD8-positive, alpha-beta T cell number J:176519
increased dendritic cell number J:176519
increased IgG2a level J:176519
increased IgG3 level J:176519
increased IgM level J:176519
increased interleukin-12 secretion J:176519
increased spleen germinal center number J:176519
increased spleen germinal center size J:176519
increased T cell number J:176519
increased T cell proliferation J:176519
Ptpn22tm1Achn/Ptpn22tm1Achn
involves: C57BL/6
abnormal Peyer's patch germinal center morphology J:90029
abnormal T cell physiology J:90029
enlarged lymph nodes J:90029
enlarged spleen J:90029
increased B cell number J:90029
increased follicular B cell number J:90029
increased IgE level J:90029
increased IgG1 level J:90029
increased IgG2a level J:90029
increased spleen germinal center number J:90029
Ptpn22tm2Achn/Ptpn22tm2Achn
B6.Cg-Ptpn22tm2Achn
abnormal double-positive T cell morphology J:147129
abnormal T cell activation J:147129
abnormal T cell subpopulation ratio J:147129
abnormal thymocyte activation J:147129
enlarged lymph nodes J:147129
increased memory T cell number J:147129
Ptpn22tm2Achn/Ptpn22tm2Achn
involves: C57BL/6
abnormal Peyer's patch germinal center morphology J:90029
abnormal T cell physiology J:90029
enlarged lymph nodes J:90029
enlarged spleen J:90029
increased B cell number J:90029
increased follicular B cell number J:90029
increased IgE level J:90029
increased IgG1 level J:90029
increased IgG2a level J:90029
increased spleen germinal center number J:90029

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/05/2024
MGI 6.24
The Jackson Laboratory